Friday, July 25, 2025

3 Magnificent Stocks That Could Double or More by 2030

How does this make you feel?


In a turbulent stock market, three Motley Fool contributors recommend investing in CRISPR Therapeutics, Summit Therapeutics, and Viking Therapeutics, which they believe could see significant gains by 2030. CRISPR Therapeutics, despite recent struggles, has a promising gene-editing therapy, Casgevy, and a robust pipeline. Summit Therapeutics is poised to challenge established drugs with its ivonescimab, while Viking Therapeutics offers potential through its GLP-1 drug, VK2735, with ongoing clinical trials targeting obesity and metabolic disorders.

Full Article

Related Posts

Sonic Automotive Q2 EPS Jumps 49 Percent

Sonic Automotive (NYSE:SAH) reported Q2 2025 earnings on July 24, revealing adjusted earnings per share of $2.19 and revenue of $3.7 billion, exceeding analyst expectations. Despite strong performance in its EchoPark used car network and a higher dividend, the company faced a net loss due to a significant non-cash impairment charge, highlighting ongoing cost and asset challenges. Want More Context? 🔎

Read more

Nasdaq Q2 Revenue Jumps 13 Percent

Nasdaq (NASDAQ:NDAQ) reported Q2 2025 results on July 24, achieving GAAP revenue of $1.31 billion and non-GAAP EPS of $0.85, exceeding estimates. The company experienced 9% growth in recurring revenue and strong operating income driven by client demand, although rising costs and longer sales cycles in regulatory technology are areas of concern. Want More Context? 🔎

Read more

The Smartest Growth Stock to Buy With $1,000 Right Now

Microsoft (NASDAQ: MSFT) recently reached $500, driven by AI growth, a strong partnership with OpenAI, and significant momentum in Azure, with potential to hit $600. However, the investor notes that there are risks involved and highlights a key signal to monitor before increasing Microsoft shares, as discussed in the accompanying video published on July 24, 2025. Want More Context? 🔎

Read more

Why TotalEnergies Stock Slumped Today

The stock of fuel and chemicals conglomerate TotalEnergies (NYSE: TTE) fell nearly 3% after the company reported second-quarter earnings, revealing net revenue of just under $44.7 billion, down from approximately $49.2 billion in the same period of 2024. In contrast, the S&P 500 index managed a slight gain on the same day. Want More Context? 🔎

Read more

The Smartest Cryptocurrency to Buy With $1,000 Right Now

Many cryptocurrencies have experienced significant gains recently, with XRP rising 60%, Ethereum more than doubling, and Bitcoin increasing by 27%. However, Polkadot, despite launching a next-generation technology upgrade, has only grown 19% in three months and remains down 40% over three years, suggesting it may present a more attractive investment opportunity compared to its peers. Want More Context? 🔎

Read more

Welcome Back!

Login to your account below

Retrieve your password

Please enter your username or email address to reset your password.